世界の皮下注生物学的製剤市場2021-2025

【英語タイトル】Global Subcutaneous Biologics Market Research Report 2021-2025

9Dimen Researchが出版した調査資料(DMN21JY4095)・商品コード:DMN21JY4095
・発行会社(調査会社):9Dimen Research
・発行日:2021年4月(※2023年版があります。お問い合わせください)
・ページ数:137
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)3,200 ⇒換算¥416,000見積依頼/購入/質問フォーム
Global/Corporate User(法人閲覧用)5,800 ⇒換算¥754,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料は、世界の皮下注生物学的製剤市場2021-2025について調査・分析し、皮下注生物学的製剤の世界市場規模、市場予測、市場動向、上流市場分析、下流市場分析、アジア市場動向、北アメリカ市場動向、ヨーロッパ市場動向、マーケティングチャネル分析、投資可能性分析、メーカー分析などの情報を掲載しています。また、種類別(シリンジ、ウェアラブル型注射器、自動型注射器、インプラント、ペン型注射器、……など)、用途別(病院薬局、小売薬局、ドラッグストア、オンライン薬局、……など)のセグメント情報も収録しています。
・皮下注生物学的製剤の市場概要
・皮下注生物学的製剤の上流・下流市場分析
・皮下注生物学的製剤のアジア市場:市場分析(製品開発、競争環境、市場動向等)
・皮下注生物学的製剤のアジア市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・皮下注生物学的製剤のアジア市場:主要メーカー分析(Abbott Laboratories 、Pfizer Inc.、Genentech Inc. 、Novartis AG 、Biogen Idec 、AbbVie Inc. 、F. Hoffmann-La Roche AG 、Bristol-Myers Squibb、Eisai Inc. 、Takeda Pharmaceuticals Ltd.、Alnylam Pharmaceuticals 、Bayer AG 、GlaxoSmithKline、Sanofi S.A.、Boston Pharmaceuticals、……)
・皮下注生物学的製剤のアジア市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・皮下注生物学的製剤の北アメリカ市場:市場分析(製品開発、競争環境、市場動向等)
・皮下注生物学的製剤の北アメリカ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・皮下注生物学的製剤の北アメリカ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・皮下注生物学的製剤の北アメリカ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・皮下注生物学的製剤のヨーロッパ市場:市場分析(製品開発、競争環境、市場動向等)
・皮下注生物学的製剤のヨーロッパ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・皮下注生物学的製剤のヨーロッパ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・皮下注生物学的製剤のヨーロッパ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・皮下注生物学的製剤のマーケティングチャネル分析
・マクロ経済分析(中国経済、ヨーロッパ経済、アメリカ経済、日本経済、グローバル経済)
・皮下注生物学的製剤の投資可能性分析
・皮下注生物学的製剤の世界市場規模(2016-2021年推移、2021-2025年予測)
...
【レポートの概要】

Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances. In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Subcutaneous Biologics Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Subcutaneous Biologics market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Subcutaneous Biologics basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Abbott Laboratories
Pfizer Inc.
Genentech Inc.
Novartis AG
Biogen Idec
AbbVie Inc.
F. Hoffmann-La Roche AG
Bristol-Myers Squibb
Eisai Inc.
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
Bayer AG
GlaxoSmithKline
Sanofi S.A.
Boston Pharmaceuticals
……

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Syringe
Wearable injector
Automatic injector
Implants
Pen injectors
……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Subcutaneous Biologics for each application, including-
Hospital pharmacies
Retail pharmacies
Drug stores
Online pharmacies
……

【レポートの目次】

Table of Contents

Part I Subcutaneous Biologics Industry Overview

Chapter One Subcutaneous Biologics Industry Overview
1.1 Subcutaneous Biologics Definition
1.2 Subcutaneous Biologics Classification Analysis
1.2.1 Subcutaneous Biologics Main Classification Analysis
1.2.2 Subcutaneous Biologics Main Classification Share Analysis
1.3 Subcutaneous Biologics Application Analysis
1.3.1 Subcutaneous Biologics Main Application Analysis
1.3.2 Subcutaneous Biologics Main Application Share Analysis
1.4 Subcutaneous Biologics Industry Chain Structure Analysis
1.5 Subcutaneous Biologics Industry Development Overview
1.5.1 Subcutaneous Biologics Product History Development Overview
1.5.1 Subcutaneous Biologics Product Market Development Overview
1.6 Subcutaneous Biologics Global Market Comparison Analysis
1.6.1 Subcutaneous Biologics Global Import Market Analysis
1.6.2 Subcutaneous Biologics Global Export Market Analysis
1.6.3 Subcutaneous Biologics Global Main Region Market Analysis
1.6.4 Subcutaneous Biologics Global Market Comparison Analysis
1.6.5 Subcutaneous Biologics Global Market Development Trend Analysis

Chapter Two Subcutaneous Biologics Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Subcutaneous Biologics Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Subcutaneous Biologics Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Subcutaneous Biologics Market Analysis
3.1 Asia Subcutaneous Biologics Product Development History
3.2 Asia Subcutaneous Biologics Competitive Landscape Analysis
3.3 Asia Subcutaneous Biologics Market Development Trend

Chapter Four 2016-2021 Asia Subcutaneous Biologics Productions Supply Sales Demand Market Status and Forecast
4.1 2016-2021 Subcutaneous Biologics Production Overview
4.2 2016-2021 Subcutaneous Biologics Production Market Share Analysis
4.3 2016-2021 Subcutaneous Biologics Demand Overview
4.4 2016-2021 Subcutaneous Biologics Supply Demand and Shortage
4.5 2016-2021 Subcutaneous Biologics Import Export Consumption
4.6 2016-2021 Subcutaneous Biologics Cost Price Production Value Gross Margin

Chapter Five Asia Subcutaneous Biologics Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information


Chapter Six Asia Subcutaneous Biologics Industry Development Trend
6.1 2021-2025 Subcutaneous Biologics Production Overview
6.2 2021-2025 Subcutaneous Biologics Production Market Share Analysis
6.3 2021-2025 Subcutaneous Biologics Demand Overview
6.4 2021-2025 Subcutaneous Biologics Supply Demand and Shortage
6.5 2021-2025 Subcutaneous Biologics Import Export Consumption
6.6 2021-2025 Subcutaneous Biologics Cost Price Production Value Gross Margin

Part III North American Subcutaneous Biologics Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Subcutaneous Biologics Market Analysis
7.1 North American Subcutaneous Biologics Product Development History
7.2 North American Subcutaneous Biologics Competitive Landscape Analysis
7.3 North American Subcutaneous Biologics Market Development Trend

Chapter Eight 2016-2021 North American Subcutaneous Biologics Productions Supply Sales Demand Market Status and Forecast
8.1 2016-2021 Subcutaneous Biologics Production Overview
8.2 2016-2021 Subcutaneous Biologics Production Market Share Analysis
8.3 2016-2021 Subcutaneous Biologics Demand Overview
8.4 2016-2021 Subcutaneous Biologics Supply Demand and Shortage
8.5 2016-2021 Subcutaneous Biologics Import Export Consumption
8.6 2016-2021 Subcutaneous Biologics Cost Price Production Value Gross Margin

Chapter Nine North American Subcutaneous Biologics Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information


Chapter Ten North American Subcutaneous Biologics Industry Development Trend
10.1 2021-2025 Subcutaneous Biologics Production Overview
10.2 2021-2025 Subcutaneous Biologics Production Market Share Analysis
10.3 2021-2025 Subcutaneous Biologics Demand Overview
10.4 2021-2025 Subcutaneous Biologics Supply Demand and Shortage
10.5 2021-2025 Subcutaneous Biologics Import Export Consumption
10.6 2021-2025 Subcutaneous Biologics Cost Price Production Value Gross Margin

Part IV Europe Subcutaneous Biologics Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Subcutaneous Biologics Market Analysis
11.1 Europe Subcutaneous Biologics Product Development History
11.2 Europe Subcutaneous Biologics Competitive Landscape Analysis
11.3 Europe Subcutaneous Biologics Market Development Trend

Chapter Twelve 2016-2021 Europe Subcutaneous Biologics Productions Supply Sales Demand Market Status and Forecast
12.1 2016-2021 Subcutaneous Biologics Production Overview
12.2 2016-2021 Subcutaneous Biologics Production Market Share Analysis
12.3 2016-2021 Subcutaneous Biologics Demand Overview
12.4 2016-2021 Subcutaneous Biologics Supply Demand and Shortage
12.5 2016-2021 Subcutaneous Biologics Import Export Consumption
12.6 2016-2021 Subcutaneous Biologics Cost Price Production Value Gross Margin

Chapter Thirteen Europe Subcutaneous Biologics Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information


Chapter Fourteen Europe Subcutaneous Biologics Industry Development Trend
14.1 2021-2025 Subcutaneous Biologics Production Overview
14.2 2021-2025 Subcutaneous Biologics Production Market Share Analysis
14.3 2021-2025 Subcutaneous Biologics Demand Overview
14.4 2021-2025 Subcutaneous Biologics Supply Demand and Shortage
14.5 2021-2025 Subcutaneous Biologics Import Export Consumption
14.6 2021-2025 Subcutaneous Biologics Cost Price Production Value Gross Margin

Part V Subcutaneous Biologics Marketing Channels and Investment Feasibility

Chapter Fifteen Subcutaneous Biologics Marketing Channels Development Proposals Analysis
15.1 Subcutaneous Biologics Marketing Channels Status
15.2 Subcutaneous Biologics Marketing Channels Characteristic
15.3 Subcutaneous Biologics Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Subcutaneous Biologics New Project Investment Feasibility Analysis
17.1 Subcutaneous Biologics Market Analysis
17.2 Subcutaneous Biologics Project SWOT Analysis
17.3 Subcutaneous Biologics New Project Investment Feasibility Analysis

Part VI Global Subcutaneous Biologics Industry Conclusions

Chapter Eighteen 2016-2021 Global Subcutaneous Biologics Productions Supply Sales Demand Market Status and Forecast
18.1 2016-2021 Subcutaneous Biologics Production Overview
18.2 2016-2021 Subcutaneous Biologics Production Market Share Analysis
18.3 2016-2021 Subcutaneous Biologics Demand Overview
18.4 2016-2021 Subcutaneous Biologics Supply Demand and Shortage
18.5 2016-2021 Subcutaneous Biologics Import Export Consumption
18.6 2016-2021 Subcutaneous Biologics Cost Price Production Value Gross Margin

Chapter Nineteen Global Subcutaneous Biologics Industry Development Trend
19.1 2021-2025 Subcutaneous Biologics Production Overview
19.2 2021-2025 Subcutaneous Biologics Production Market Share Analysis
19.3 2021-2025 Subcutaneous Biologics Demand Overview
19.4 2021-2025 Subcutaneous Biologics Supply Demand and Shortage
19.5 2021-2025 Subcutaneous Biologics Import Export Consumption
19.6 2021-2025 Subcutaneous Biologics Cost Price Production Value Gross Margin

Chapter Twenty Global Subcutaneous Biologics Industry Research Conclusions



★調査レポート[世界の皮下注生物学的製剤市場2021-2025] (コード:DMN21JY4095)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の皮下注生物学的製剤市場2021-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆